These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 9858429

  • 1. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response.
    Barry NN, McGuire JL, van Vollenhoven RF.
    J Rheumatol; 1998 Dec; 25(12):2352-6. PubMed ID: 9858429
    [Abstract] [Full Text] [Related]

  • 2. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.
    van Vollenhoven RF, Morabito LM, Engleman EG, McGuire JL.
    J Rheumatol; 1998 Feb; 25(2):285-9. PubMed ID: 9489820
    [Abstract] [Full Text] [Related]

  • 3. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
    Chang DM, Lan JL, Lin HY, Luo SF.
    Arthritis Rheum; 2002 Nov; 46(11):2924-7. PubMed ID: 12428233
    [Abstract] [Full Text] [Related]

  • 4. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
    Nordmark G, Bengtsson C, Larsson A, Karlsson FA, Sturfelt G, Rönnblom L.
    Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258
    [Abstract] [Full Text] [Related]

  • 5. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
    Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE.
    Arthritis Rheum; 2004 Sep; 50(9):2858-68. PubMed ID: 15452837
    [Abstract] [Full Text] [Related]

  • 6. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Petri MA, Lahita RG, Van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, Strand V, Kunz A, Gorelick KJ, Schwartz KE, GL601 Study Group.
    Arthritis Rheum; 2002 Jul; 46(7):1820-9. PubMed ID: 12124866
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
    Vogl D, Falk W, Dorner M, Schölmerich J, Straub RH.
    J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
    [Abstract] [Full Text] [Related]

  • 8. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
    Hartkamp A, Geenen R, Godaert GL, Bijl M, Bijlsma JW, Derksen RH.
    Ann Rheum Dis; 2010 Jun; 69(6):1144-7. PubMed ID: 19854713
    [Abstract] [Full Text] [Related]

  • 9. Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus.
    Straub RH, Zeuner M, Antoniou E, Schölmerich J, Lang B.
    J Rheumatol; 1996 May; 23(5):856-61. PubMed ID: 8724298
    [Abstract] [Full Text] [Related]

  • 10. Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus.
    Van Vollenhoven RF, McGuire JL.
    Ann Med Interne (Paris); 1996 May; 147(4):290-6. PubMed ID: 8952750
    [Abstract] [Full Text] [Related]

  • 11. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649
    [Abstract] [Full Text] [Related]

  • 12. Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus.
    Chang DM, Chu SJ, Chen HC, Kuo SY, Lai JH.
    Ann Rheum Dis; 2004 Dec; 63(12):1623-6. PubMed ID: 15547086
    [Abstract] [Full Text] [Related]

  • 13. Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphate.
    Overman CL, Hartkamp A, Bossema ER, Bijl M, Godaert GL, Bijlsma JW, Derksen RH, Geenen R.
    Lupus; 2012 Dec; 21(14):1515-21. PubMed ID: 22936125
    [Abstract] [Full Text] [Related]

  • 14. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Straub RH, Weidler C, Demmel B, Herrmann M, Kees F, Schmidt M, Schölmerich J, Schedel J.
    Ann Rheum Dis; 2004 Aug; 63(8):961-8. PubMed ID: 15249323
    [Abstract] [Full Text] [Related]

  • 15. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
    Khaw KT.
    J Endocrinol; 1996 Sep; 150 Suppl():S149-53. PubMed ID: 8943798
    [Abstract] [Full Text] [Related]

  • 16. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women.
    Cappel M, Mauger D, Thiboutot D.
    Arch Dermatol; 2005 Mar; 141(3):333-8. PubMed ID: 15781674
    [Abstract] [Full Text] [Related]

  • 17. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Härle P, Pongratz G, Weidler C, Büttner R, Schölmerich J, Straub RH.
    Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
    [Abstract] [Full Text] [Related]

  • 18. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
    Saruç M, Yüceyar H, Ayhan S, Türkel N, Tuzcuoglu I, Can M.
    Hepatogastroenterology; 2003 Jul; 50(51):771-4. PubMed ID: 12828082
    [Abstract] [Full Text] [Related]

  • 19. [Derivatives of dehydroepiandrosterone and their changes during a one-day starvation test].
    Matoulek M, Hampl R, Svacina S, Sulcová J, Haas T.
    Cas Lek Cesk; 2000 Dec 06; 139(24):772-5. PubMed ID: 11262916
    [Abstract] [Full Text] [Related]

  • 20. Hormones and lupus: defective dehydroepiandrosterone activity induces impaired interleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosus.
    Suzuki N, Suzuki T, Sakane T.
    Ann Med Interne (Paris); 1996 Dec 06; 147(4):248-52. PubMed ID: 8952743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.